The cumulative incidence of chronic graft-versus-host disease (GVHD) according to the National Institutes of Health consensus criteria was 47%.
The probability of late GVHD-free, relapse-free survival was 38% at 1 year.
Late acute GVHD and bronchiolitis obliterans had high 2-year nonrelapse mortality, 23% and 32%, respectively.